 | • レポートコード：D0GIR-02169 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、多剤耐性菌治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。多剤耐性菌治療の種類別市場規模（経口、非経口、その他）、用途別市場規模（病院、専門クリニック、回復センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Nabriva Therapeutics、Tetraphase Pharmaceuticals、Destiny Pharma、BioVersys、Nemesis Bioscience、Johnson & Johnson、Merck、Westway Health、Armata Pharmaceuticals、Allergan、Vertex Pharmaceuticals Incorporated、Roche、Pfizer、GlaxoSmithKline、Novartis、CARB-X、AbbVie、Melinta Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・多剤耐性菌治療の北米市場（アメリカ、カナダ、メキシコ） ・多剤耐性菌治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・多剤耐性菌治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・多剤耐性菌治療の南米市場（ブラジル、アルゼンチン） ・多剤耐性菌治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、非経口、その他 ・用途別分析：病院、専門クリニック、回復センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Multidrug Resistant Bacteria Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Multidrug Resistant Bacteria Treatment sales will be xx in 2020 from Multidrug Resistant Bacteria Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Multidrug Resistant Bacteria Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Multidrug Resistant Bacteria Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Multidrug Resistant Bacteria Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Multidrug Resistant Bacteria Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Multidrug Resistant Bacteria Treatment market has been segmented into:
Oral
Parenteral
Others
By Application, Multidrug Resistant Bacteria Treatment has been segmented into:
Hospital
Special Clinic
Recovery Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Multidrug Resistant Bacteria Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Multidrug Resistant Bacteria Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Multidrug Resistant Bacteria Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Multidrug Resistant Bacteria Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Multidrug Resistant Bacteria Treatment Market Share Analysis
Multidrug Resistant Bacteria Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Multidrug Resistant Bacteria Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Multidrug Resistant Bacteria Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Multidrug Resistant Bacteria Treatment are:
Nabriva Therapeutics
Tetraphase Pharmaceuticals
Destiny Pharma
BioVersys
Nemesis Bioscience
Johnson & Johnson
Merck
Westway Health
Armata Pharmaceuticals
Allergan
Vertex Pharmaceuticals Incorporated
Roche
Pfizer
GlaxoSmithKline
Novartis
CARB-X
AbbVie
Melinta Therapeutics
Among other players domestic and global, Multidrug Resistant Bacteria Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Multidrug Resistant Bacteria Treatment Market Overview
1.1 Product Overview and Scope of Multidrug Resistant Bacteria Treatment
1.2 Classification of Multidrug Resistant Bacteria Treatment by Route of Administration
1.2.1 Global Multidrug Resistant Bacteria Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Route of Administration in 2019
1.2.3 Oral
1.2.4 Parenteral
1.2.5 Others
1.3 Global Multidrug Resistant Bacteria Treatment Market by Application
1.3.1 Overview: Global Multidrug Resistant Bacteria Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Multidrug Resistant Bacteria Treatment Market by Regions
1.4.1 Global Multidrug Resistant Bacteria Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Multidrug Resistant Bacteria Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Multidrug Resistant Bacteria Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Multidrug Resistant Bacteria Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Multidrug Resistant Bacteria Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Multidrug Resistant Bacteria Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Multidrug Resistant Bacteria Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Multidrug Resistant Bacteria Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Multidrug Resistant Bacteria Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Multidrug Resistant Bacteria Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Nabriva Therapeutics
2.1.1 Nabriva Therapeutics Details
2.1.2 Nabriva Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Nabriva Therapeutics SWOT Analysis
2.1.4 Nabriva Therapeutics Product and Services
2.1.5 Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tetraphase Pharmaceuticals
2.2.1 Tetraphase Pharmaceuticals Details
2.2.2 Tetraphase Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Tetraphase Pharmaceuticals SWOT Analysis
2.2.4 Tetraphase Pharmaceuticals Product and Services
2.2.5 Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Destiny Pharma
2.3.1 Destiny Pharma Details
2.3.2 Destiny Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Destiny Pharma SWOT Analysis
2.3.4 Destiny Pharma Product and Services
2.3.5 Destiny Pharma Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioVersys
2.4.1 BioVersys Details
2.4.2 BioVersys Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioVersys SWOT Analysis
2.4.4 BioVersys Product and Services
2.4.5 BioVersys Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nemesis Bioscience
2.5.1 Nemesis Bioscience Details
2.5.2 Nemesis Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Nemesis Bioscience SWOT Analysis
2.5.4 Nemesis Bioscience Product and Services
2.5.5 Nemesis Bioscience Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck Product and Services
2.7.4 Merck Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Westway Health
2.8.1 Westway Health Details
2.8.2 Westway Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Westway Health Product and Services
2.8.4 Westway Health Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Armata Pharmaceuticals
2.9.1 Armata Pharmaceuticals Details
2.9.2 Armata Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Armata Pharmaceuticals Product and Services
2.9.4 Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergan Product and Services
2.10.4 Allergan Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vertex Pharmaceuticals Incorporated
2.11.1 Vertex Pharmaceuticals Incorporated Details
2.11.2 Vertex Pharmaceuticals Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vertex Pharmaceuticals Incorporated Product and Services
2.11.4 Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Roche
2.12.1 Roche Details
2.12.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Roche Product and Services
2.12.4 Roche Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Pfizer Product and Services
2.13.4 Pfizer Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 GlaxoSmithKline Product and Services
2.14.4 GlaxoSmithKline Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novartis Product and Services
2.15.4 Novartis Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 CARB-X
2.16.1 CARB-X Details
2.16.2 CARB-X Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 CARB-X Product and Services
2.16.4 CARB-X Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 AbbVie Product and Services
2.17.4 AbbVie Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Melinta Therapeutics
2.18.1 Melinta Therapeutics Details
2.18.2 Melinta Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Melinta Therapeutics Product and Services
2.18.3 Melinta Therapeutics Multidrug Resistant Bacteria Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Multidrug Resistant Bacteria Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Multidrug Resistant Bacteria Treatment Players Market Share
3.2.2 Top 10 Multidrug Resistant Bacteria Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Multidrug Resistant Bacteria Treatment Revenue and Market Share by Regions
4.2 North America Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
5 North America Multidrug Resistant Bacteria Treatment Revenue by Countries
5.1 North America Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
5.2 USA Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
6 Europe Multidrug Resistant Bacteria Treatment Revenue by Countries
6.1 Europe Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
6.2 Germany Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
6.4 France Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue by Countries
7.1 Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
7.2 China Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
7.5 India Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
8 South America Multidrug Resistant Bacteria Treatment Revenue by Countries
8.1 South America Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
8.2 Brazil Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Multidrug Resistant Bacteria Treatment by Countries
9.1 Middle East & Africa Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Multidrug Resistant Bacteria Treatment Revenue and Market Share by Route of Administration (2015-2020)
10.2 Global Multidrug Resistant Bacteria Treatment Market Forecast by Route of Administration (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Parenteral Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Multidrug Resistant Bacteria Treatment Market Segment by Application
11.1 Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Application (2015-2020)
11.2 Multidrug Resistant Bacteria Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Special Clinic Revenue Growth (2015-2020)
11.5 Recovery Center Revenue Growth (2015-2020)
12 Global Multidrug Resistant Bacteria Treatment Market Size Forecast (2021-2025)
12.1 Global Multidrug Resistant Bacteria Treatment Market Size Forecast (2021-2025)
12.2 Global Multidrug Resistant Bacteria Treatment Market Forecast by Regions (2021-2025)
12.3 North America Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
12.6 South America Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Multidrug Resistant Bacteria Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Multidrug Resistant Bacteria Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Multidrug Resistant Bacteria Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Multidrug Resistant Bacteria Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Multidrug Resistant Bacteria Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Nabriva Therapeutics Corporate Information, Location and Competitors
Table 7. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Major Business
Table 8. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Nabriva Therapeutics SWOT Analysis
Table 10. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Product and Solutions
Table 11. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Tetraphase Pharmaceuticals Corporate Information, Location and Competitors
Table 13. Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Major Business
Table 14. Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Tetraphase Pharmaceuticals SWOT Analysis
Table 16. Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Product and Solutions
Table 17. Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Destiny Pharma Corporate Information, Location and Competitors
Table 19. Destiny Pharma Multidrug Resistant Bacteria Treatment Major Business
Table 20. Destiny Pharma Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Destiny Pharma SWOT Analysis
Table 22. Destiny Pharma Multidrug Resistant Bacteria Treatment Product and Solutions
Table 23. Destiny Pharma Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. BioVersys Corporate Information, Location and Competitors
Table 25. BioVersys Multidrug Resistant Bacteria Treatment Major Business
Table 26. BioVersys Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 27. BioVersys SWOT Analysis
Table 28. BioVersys Multidrug Resistant Bacteria Treatment Product and Solutions
Table 29. BioVersys Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Nemesis Bioscience Corporate Information, Location and Competitors
Table 31. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Major Business
Table 32. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Nemesis Bioscience SWOT Analysis
Table 34. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Product and Solutions
Table 35. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Multidrug Resistant Bacteria Treatment Major Business
Table 38. Johnson & Johnson Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Multidrug Resistant Bacteria Treatment Product and Solutions
Table 41. Johnson & Johnson Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Merck Corporate Information, Location and Competitors
Table 43. Merck Multidrug Resistant Bacteria Treatment Major Business
Table 44. Merck Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Merck SWOT Analysis
Table 46. Merck Multidrug Resistant Bacteria Treatment Product and Solutions
Table 47. Merck Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Westway Health Corporate Information, Location and Competitors
Table 49. Westway Health Multidrug Resistant Bacteria Treatment Major Business
Table 50. Westway Health Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Westway Health SWOT Analysis
Table 52. Westway Health Multidrug Resistant Bacteria Treatment Product and Solutions
Table 53. Westway Health Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Armata Pharmaceuticals Corporate Information, Location and Competitors
Table 55. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Major Business
Table 56. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Armata Pharmaceuticals SWOT Analysis
Table 58. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Product and Solutions
Table 59. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Allergan Corporate Information, Location and Competitors
Table 61. Allergan Multidrug Resistant Bacteria Treatment Major Business
Table 62. Allergan Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Allergan SWOT Analysis
Table 64. Allergan Multidrug Resistant Bacteria Treatment Product and Solutions
Table 65. Allergan Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Vertex Pharmaceuticals Incorporated Corporate Information, Location and Competitors
Table 67. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Major Business
Table 68. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Vertex Pharmaceuticals Incorporated SWOT Analysis
Table 70. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Product and Solutions
Table 71. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Roche Corporate Information, Location and Competitors
Table 73. Roche Multidrug Resistant Bacteria Treatment Major Business
Table 74. Roche Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Roche SWOT Analysis
Table 76. Roche Multidrug Resistant Bacteria Treatment Product and Solutions
Table 77. Roche Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Pfizer Corporate Information, Location and Competitors
Table 79. Pfizer Multidrug Resistant Bacteria Treatment Major Business
Table 80. Pfizer Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 81. Pfizer SWOT Analysis
Table 82. Pfizer Multidrug Resistant Bacteria Treatment Product and Solutions
Table 83. Pfizer Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. GlaxoSmithKline Corporate Information, Location and Competitors
Table 85. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Major Business
Table 86. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 87. GlaxoSmithKline SWOT Analysis
Table 88. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Product and Solutions
Table 89. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Novartis Corporate Information, Location and Competitors
Table 91. Novartis Multidrug Resistant Bacteria Treatment Major Business
Table 92. Novartis Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 93. Novartis SWOT Analysis
Table 94. Novartis Multidrug Resistant Bacteria Treatment Product and Solutions
Table 95. Novartis Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. CARB-X Corporate Information, Location and Competitors
Table 97. CARB-X Multidrug Resistant Bacteria Treatment Major Business
Table 98. CARB-X Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 99. CARB-X SWOT Analysis
Table 100. CARB-X Multidrug Resistant Bacteria Treatment Product and Solutions
Table 101. CARB-X Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. AbbVie Corporate Information, Location and Competitors
Table 103. AbbVie Multidrug Resistant Bacteria Treatment Major Business
Table 104. AbbVie Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 105. AbbVie SWOT Analysis
Table 106. AbbVie Multidrug Resistant Bacteria Treatment Product and Solutions
Table 107. AbbVie Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Route of Administration and Application
Table 109. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Major Business
Table 110. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Total Revenue (USD Million) (2017-2018)
Table 111. Melinta Therapeutics SWOT Analysis
Table 112. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Product and Solutions
Table 113. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Players (2015-2020)
Table 115. Global Multidrug Resistant Bacteria Treatment Revenue Share by Players (2015-2020)
Table 116. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Regions (2015-2020)
Table 118. North America Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
Table 119. North America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Table 120. Europe Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Multidrug Resistant Bacteria Treatment Revenue by Countries (2015-2020)
Table 123. South America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Table 126. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) by Type (2015-2020)
Table 127. Global Multidrug Resistant Bacteria Treatment Revenue Share by Type (2015-2020)
Table 128. Global Multidrug Resistant Bacteria Treatment Revenue Forecast by Type (2021-2025)
Table 129. Global Multidrug Resistant Bacteria Treatment Revenue by Application (2015-2020)
Table 130. Global Multidrug Resistant Bacteria Treatment Revenue Share by Application (2015-2020)
Table 131. Global Multidrug Resistant Bacteria Treatment Revenue Forecast by Application (2021-2025)
Table 132. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Multidrug Resistant Bacteria Treatment Picture
Figure 2. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Route of Administration in 2019
Figure 3. Oral Picture
Figure 4. Parenteral Picture
Figure 5. Others Picture
Figure 6. Multidrug Resistant Bacteria Treatment Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Special Clinic Picture
Figure 9. Recovery Center Picture
Figure 10. Global Multidrug Resistant Bacteria Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Multidrug Resistant Bacteria Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Multidrug Resistant Bacteria Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Multidrug Resistant Bacteria Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries in 2019
Figure 43. China Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Multidrug Resistant Bacteria Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Multidrug Resistant Bacteria Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Multidrug Resistant Bacteria Treatment Revenue Share by Type in 2019
Figure 60. Global Multidrug Resistant Bacteria Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Oral Revenue Growth Rate (2015-2020)
Figure 62. Global Parenteral Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Multidrug Resistant Bacteria Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Multidrug Resistant Bacteria Treatment Revenue Share by Application in 2019
Figure 66. Global Multidrug Resistant Bacteria Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Special Clinic Revenue Growth Rate (2015-2020)
Figure 69. Global Recovery Center Revenue Growth Rate (2015-2020)
Figure 70. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Multidrug Resistant Bacteria Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Multidrug Resistant Bacteria Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Multidrug Resistant Bacteria Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
バクテリアフィルターの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Bacteria Filter market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 滅菌バクテリアフィルターの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Sterile Bacteria Filter market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 乳酸菌飲料の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Lactic Acid Bacteria Beverage market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 細菌検出キットの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Bacteria Detection Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- スキッド耐性紙包装の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Skid Resistant Paper Packaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skid Resistant…